Abstract
Purpose. This study aims to assess the drug absorption kinetics of three drugs and compare their resulting first-order intestinal permeation rate constants to their Caco-2 monolayer permeabilities.
Methods. In vitro dissolution — in vivo absorption analysis was conducted on four formulations of each ranitidine HC1, metoprolol tartrate, and piroxicam to yield apparent and "true” human clinical permeation rate constants. Drug permeability coefficients through Caco-2 monolayers were also determined.
Results. In vitro dissolution — in vivo absorption analysis revealed different relative and absolute contributions of dissolution and intestinal permeation to overall drug absorption kinetics for various drug formulations and yielded estimates of each drug's true and apparent human intestinal permeation rate constant [k p = 0.225 hr−1, 0.609 hr−l, and 9.00 hr−1 for ranitidine, metoprolol, and piroxicam, respectively]. A rank order relationship was observed for both the apparent and true permeation rate constant with Caco-2 monolayer permeability. The decrease in the true permeation rate constant relative to the apparent permeation rate constant was most significant (almost three-fold) for the least permeable compound, ranitidine.
Conclusions. There were marked differences in the permeation kinetics of ranitidine, metoprolol, and piroxicam. The possibility of an association between absorption kinetics from dosage forms in humans and Caco-2 monolayer permeability may allow for a direct kinetic interpretation of human oral absorption from Caco-2 monolayer permeability values.
Similar content being viewed by others
REFERENCES
J. E. Polli, G. S. Rekhi, L. L. Augsburger, and V. P. Shah. J. Pharm. Sci. 86:690–700 (1997).
R. T. Borchardt, P. L. Smith, and G. Wilson. Models for Assessing Drug Absorption and Metabolism, Plenum Press, New York, 1996.
I. J. Hildalgo, T. J. Raub, and R. T. Borchardt. Gastroenterology 96:736–749 (1989).
W. Rubas, N. Jezyk, and G. M. Grass. Pharm. Res. 10:113–118 (1993).
M. Hu, L. Zheng, J. Chen, L. Liu, Y. Zhu, A. H. Dantzig, and R. E. Stratford. Pharm. Res. 12:1120–1125 (1995).
P. Artursson and J. Karlsson. Biochem. Biophys. Res. Commun. 175:880–885 (1991).
R. E. Notari, J. L. DeYoung, and R. H. Reuning. J. Pharm. Sci. 61:135–138 (1972).
D. Perrier and M. Gibaldi. J. Pharm. Sci. 62:225–228 (1972).
J. E. Polli, J. R. Crison, and G. L. Amidon. J. Pharm. Sci. 85:753–760 (1996).
L. J. Leeson and H. Weintraub. J. Pharm. Sci. 62:1936–1941 (1972).
D. A. Piscitelli, J. McGlone Dalby, C. Propst, S. Goskonda, P. Schwartz, L. J. S. Goskonda, C. Propst, L. Augsburger, P. Schwartz, and L. Lesko. Pharm. Res. 11:S-163 (1994).
D. A. Piscitelli, J. McGlone Dalby, L. Augsburger, V. P. Shah, L. J. Lesko, and D. Young. Pharm. Res. 12:S-417 (1995).
D. A. Piscitelli, J. McGlone Dalby, C. Propst, S. Goskonda, P. Schwartz, L. J. Lesko, V. Shah, D. Young, and L. L. Augsburger. To be submitted to Pharm. Dev. Technol.
D. A. Piscitelli, S. Bigora, C. Propst, S. Goskonda, P. Schwartz, L. J. Lesko, L. L. Augsburger, and D. Young. Pharm. Dev. Technol. (in press).
G. S. Rekhi, N. E. Eddington, M. J. Fossler, P. Schwartz, L. J. Lesko, and L. L. Augsburger. Pharm. Dev. Technol. 2:11–24 (1997).
S. M. Grant, H. D. Langtry, and R. N. Brogden. Drugs 37:801–870 (1989).
S. S. Davis, J. G. Hardy, and J. W. Fara. Gut 27:886–892 (1986).
K. T. Olkkola, A. V. Brunetto, and M. J. Mattila. Clin Pharmacokinet. 26:107–120 (1994).
U. Fagerholm, M. Johansson, and H. Lennernas. Pharm. Res. 13:1336–1342 (1996).
D. Fleisher. Gastrointestinal Transport of Peptides: Experimental Systems. In M. D. Taylor and G. L. Amidon (eds.), Peptide-based Drug Design: Controlling Transport and Metabolism, American Chemical Society, Washington, DC, 1995, pp. 501–523.
The International Commission on Radiological Protection, Report on the Task Group on Reference Man, Pergamon Press, Oxford, 1974.
J. B. Dressman, G. L. Amidon, and D. Fleisher. J. Pharm. Sci. 74:588–589 (1985).
L. S. Gan, P. H. Hsyu, J. F. Pritchard, and D. Thakker. Pharm. Res. 10:1722–1725 (1993).
P. Artursson, A. Ungell, and J. Lofroth. Pharm. Res. 10:1123–1129 (1993).
A. Collett, E. Sims, D. Walker, Y. L. He, J. Ayrton, M. Rowland, and G. Warhurst. Pharm. Res. 13:216–221 (1996).
S. E. Crowe and M. H. Purdue. Gastroenterology 105:764–772 (1993).
H. Lennernas, L. Knutson, T. Knutson, L. Lesko, T. Salmonson, and G. L. Amidon. Pharm. Res. 12:S-295 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Polli, J.E., Ginski, M.J. Human Drug Absorption Kinetics and Comparison to Caco-2 Monolayer Permeabilities. Pharm Res 15, 47–52 (1998). https://doi.org/10.1023/A:1011992518592
Issue Date:
DOI: https://doi.org/10.1023/A:1011992518592